Akero Clinical Study Site

Taipei 10048

0 studies enrolling now · 1 studies all time

What they study most

NAFLD/MASLD, NASH/MASH

Studies at this site

• A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Running, not enrolling